Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Express Scripts
AstraZeneca
Medtronic
Baxter
Moodys
McKesson

Last Updated: January 26, 2020

DrugPatentWatch Database Preview

Patent: 9,974,764

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Summary for Patent: 9,974,764
Title:Compositions and methods of use of phorbol esters in the treatment of neoplasms
Abstract: Methods and compositions containing a phorbol ester or a derivative of a phorbol ester are provided for the treatment of chronic and acute conditions. Such conditions may be caused by disease, be symptoms, treatments, or sequelae of disease. The phorbol esters described are particularly useful in the treatment of neoplastic diseases and/or managing the side effects of chemotherapeutic and radiotherapeutic treatments of neoplastic diseases.
Inventor(s): Han; Zheng Tao (Eugene, OR), Chen; Hung-Fong (Taipei, TW)
Assignee: Biosuccess Biotech Co. Ltd. (Santa Clara, CA)
Application Number:14/026,473
Patent Claims:see list of patent claims

Details for Patent 9,974,764

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Wyeth Pharms Inc MYLOTARG gemtuzumab ozogamicin VIAL;SINGLE-DOSE 761060 001 2018-04-09   Start Trial Biosuccess Biotech Co. Ltd. (Santa Clara, CA) 2027-01-31 RX Orphan search
Chiron PROLEUKIN aldesleukin VIAL 103293 001 1992-05-05   Start Trial Biosuccess Biotech Co. Ltd. (Santa Clara, CA) 2027-01-31 RX search
Merck ELSPAR asparaginase VIAL 101063 001 1978-01-10   Start Trial Biosuccess Biotech Co. Ltd. (Santa Clara, CA) 2027-01-31 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

International Patent Family for US Patent 9,974,764

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Merck
McKesson
Boehringer Ingelheim
McKinsey
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.